Key facts
- Notable investors include Changzhou Hi-tech Group, Hangzhou Huafang Chuangliang Investment Management, Holley Group.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Jiaweida Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Jiaweida Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jiaweida Biotechnology
Opeartor of a biotechnology company focusing on the research and development, and production of biological raw materials. The company is positioned as a research and development, production and sales of biological raw materials and synthetic biology products.
- Sector
- Healthcare
- HQ
- Wuhan, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Jiaweida Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jiaweida Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jiaweida Biotechnology in its N-PORT filings yet. We sweep new filings monthly.